Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease The DIPAK 1 Randomized Clinical Trial

Author(s):
Meijer, E.; Visser, F.W.; Aerts, R.M.M. van; Blijdorp, C.J.; Casteleijn, N.F.; D'Agnolo, H.M.A.; Dekker, S.E.I.; Drenth, J.P.H.; Fijter, J. de; Gastel, M.D.A. van; Gevers, T.J.; Lantinga, M.A.; Losekoot, M.; Messchendorp, A.L.; Neijenhuis, M.K.; Pena, M.J.; Peters, D.J.M. (0000-0001-6974-7143); Salih, M.; Soonawala, D.; Spithoven, E.M.; Wetzels, J.F.; Zietse, R.; Gansevoort, R.T.; DIPAK-1 Investigators
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-11-20
Language
English
Is part of
Journal of the American Medical Association (2018), Vol. 320, no. 19, p. 2010-2019
hdl
1887/96001
doi
10.1001/jama.2018.15870